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Functionalized and chiral N-heterocycles represent widely exploited and valuable synthetic units, where an ability to gain access to either enantiomer of the target heterocycle is often an important issue. 1 Asymmetric alkene reduction methods 2 are especially attractive in this area since other functional groups present in the alkene substrate e.g. a carbonyl moiety often serves to direct the catalytic reduction step; such functionality can then also be of value in terms of the synthetic flexibility inherent within the reduction product.
In terms of general C=C reduction, high enantioselectivity has been reported for a range of functionalized alkenyl substrates, such as acrylates 3 and, relevant here, and amino/amidoacrylates. 4 Similarly, cyclic enamines are effective substrates for asymmetric reduction leading to substituted 5-, 6-and 7-ring N-heterocycles. 5 Scheme 1.
Our interest in this area has focused on reduction of an unusual class of -amidoacrylates (i.e. lactams) of general structure 1 (n=1-3). The potential of these systems is exemplified by lactam 2 (1, n=2); reduction of the readily available ester 2a 6 provides piperidone 3a (a  2 -amino acid derivative) which has served as a key intermediate in the synthesis of cytisine as well as of a series of cytisine variants (Scheme 1). 7 In earlier work, we developed an asymmetric approach to cytisine by exploiting an ability to carry out a kinetic resolution of methyl ester 3a using -chymotrypsin (-CHY). 8 This provided acid (S)-3b (>64% ee; 48% yield), and (unreacted) ester (R)-(+)-3a (>98% ee; 42% yield). While useful, such resolution processes are, however, inherently inefficient. Catalytic asymmetric reduction of 2a/b, which is a more attractive option, had been explored using standard methods reported previously for acrylates. However, these efforts enjoyed limited success; we obtained low enantioselectivities and poor conversions. 9 One factor affecting the levels of asymmetric induction observed may link to the relative spatial disposition of the lactam carbonyl (as a potential ligand and directing group) with respect to either or both of the C=C or carboxylate functions. 10 Given these limitations, the value and attractiveness of enantiomerically pure piperidinone 3a/b in other contexts, 11 and the opportunity to develop a methodology applicable to a wider range of substrates, we undertook a more extensive screening program to assess the potential for the asymmetric reduction of methyl ester 2a and carboxylic acid 2b. A wide range of metal catalysts, ligands and reaction conditions were evaluated within AstraZeneca. Having screened a range of parameters, effective reaction conditions were identified, which are shown in Scheme 2, and asymmetric reduction of acid 2b was achieved to product (S)-(-)-3b in over 97% ee with Rh catalysis in combination with (S,Sp)-WALPHOS 4 as ligand. 12 High selectivity was observed only with carboxylic acid 2b; methyl ester 2a did undergo reduction but with a negligible level of enantiomeric induction under all of the different conditions evaluated. Further, the isolated (after purification) yield (65%) of (S)-3b is likely a result of the high pressures involved necessary to achieve reasonable conversion under which N-debenzylation appeared to begin to compete. Scheme 2. Asymmetric reduction of 2b to give (S)-3b.
The stereochemical outcome of this asymmetric reduction process (in terms of generating (S)-(-)-3b) was established by comparison to the piperidinone products obtained from enzymatic kinetic resolution. In this earlier work we had obtained as the unreacted enantiomer, ester (R)-(+)-3a in high enantiomeric excess which we had then converted to (unnatural) (+)-cytisine.
We have further explored the scope of this reduction methodology and examined the viability of the corresponding pyrrolidine and azepane-based lactams 1 (n=0 and 2 respectively) given that, alongside piperidone 2, these would provide a homologous series of enantiomerically-enriched, functionalized and synthetically versatile N-heterocyclic units.
In the case of the pyrrolidine variant, then the enzymatic kinetic resolution of (±)-5a (to provide access to enriched ester (R)-(-)-5a and acid (S)-(+)-5b) has been reported. 13 This earlier work provided us with a basis of a later structural assignment but two potential reduction substrates needed to be considered: the -aminoacrylates 6a/b 14 (the  4,5 -lactam, analogous to 2a/b) and the corresponding  3,4 -isomer (incorporating a fumarate subunit), previously reported as the methyl ester 7. 15 The synthesis of -aminoacrylate 6a/b we have developed is shown in Scheme 3 and is based on formylation of diethyl succinate followed by enamine formation (using benzylamine), cyclization of which was best carried out under strongly basic conditions. Given our experience in the piperidinone series, we focused attention on the use of the corresponding carboxylic acid 6b as the reduction substrate but the conversion of ester 6a to acid 6b proved to be surprisingly difficult; product degradation under standard conditions appeared to be facile. 16 Optimal conditions developed are shown in Scheme 3 and, once isolated, acid 6b is crystalline, stable and easily handled.
Reduction of acid 6b followed a very similar course to that of 2b and the (S)-(+)-carboxylic acid 5b was isolated in 75% yield and in 97% ee The configuration of 5b was established by comparison with optical rotation data reported for this compound derived by enzymatic resolution 13 and clearly 2b and 6b undergo asymmetric reduction in the same sense as one another under these Rh/WALPHOS conditions. We were interested in the behavior of the isomeric lactam 7 under reduction conditions, recognizing that C=C isomerization could be involved in the reduction of -aminoacrylates such as 6b. However, our attempts to reproduce the route reported to 7 failed to give the product claimed; 15 see Supporting Information. In our hands the only product obtained these conditions was methyl ester 6c (i.e. the  4,5 -lactam isomer) which was isolated in 70% yield.
Scheme 3. Synthesis of 6a and 6b; asymmetric reduction of 6b
The azepane variant 9 was prepared using a nitrone-based Beckmann rearrangement (Scheme 4) which was based on the earlier work of both Barton 17a and Ward. 17b To avoid a problematic separation of isomeric lactam products, it was critical to isolate the individual nitrone isomers 8 (isolated as a 3:1 mixture of E/Z isomers) prior to rearrangement. In this way azepene 9a was obtained in 40% yield and converted efficiently to the corresponding acid 9b.
Reduction of 9b, under the conditions applied to 1b and 5b, provided the azepane 10 but in 10% ee and the absolute configuration of the predominant product was not established. This was a surprising result given the relatively small structural modification involved, and further work will be needed to probe the mechanism by which this set of substrates interacts with the Rh/ligand complex. 18 Given that both pyrrolidinone 5a and piperidone 3a are viable substrates for kinetic resolution using α-chymotrypsin-CHY), we have evaluated methyl ester 11 under these conditions (Scheme 5). Ester 11 was obtained in 85% yield by hydrogenation of 9a (see Supporting Information).
Scheme 4. Synthesis of 9a and 9b; asymmetric reduction of 9b
At pH 7.4, racemic 11 underwent selective hydrolysis and the corresponding acid 10 was isolated in 31% yield and 78% ee and the unreacted ester 11 was recovered in 46% yield and 97% ee (as assessed by chiral HPLC). 19 We have not assigned the absolute configurations of these products and this process has not been optimized further in terms of yields and enantiomeric purities. Scheme 5. Enzymatic kinetic resolution of (±)-11
In summary, we have shown that an unusual but synthetically useful class of heterocyclic -aminoacrylates undergo efficient asymmetric reduction with a Rh-WALPHOS catalyst combination. This process works efficiently for the pyrrolidinone and piperidinone carboxylic acid substrates 6b and 2b respectively but the level of enantiomeric selectivity dramatically diminished in the case of the seven-ring azepine substrate 9b.
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(18) The steep drop-off in % ee with the seven-ring substrate 9b was surprising, but 9b has not been screened separately against a bank of metals/ligands. Incorporating three sp 3 centers, molecular models suggest that 9b is significantly more puckered than either the 5-or 6-ring variants which may affect the relative stability of the diasteromeric substrate-metal complexes. Nicolaou has reported the asymmetric reduction of N-acyl heterocyclic dehydroamino esters (to give -amino esters) where the opposite trend i.e. increasing enantioselectivity with increasing ring size was observed. However, it is probable that these substrates involve a chelated metal complex involving the N-acyl moiety which is not possible with the substrates we report here. Nicolaou, K. C.; Shi, G.-Q.; Namoto, K.; Bernal, F. Chem. Commun. 1998, 1757. (19) Enantiomeric purities reported were determined by chiral HPLC using racemates as standards.
